Trials / Unknown
UnknownNCT04186026
Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.
Effect of Combination of the Gut Hormones Neurotensin and GLP-1 on Physiological Regulation of Appetite and Food Intake
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.
Detailed description
Neurotensin (NT), a gut hormone and neuropeptide, and GLP-1, as well a gut hormone, increases in circulation after bariatric surgery in rodents and humans and inhibit food intake in mice. Studies in rodents have shown that a GLP-1 receptor agonist and long acting neurotensin inhibit food intake. This study investigates whether the synergistic anorexic effects of neurotensin and GLP-1 agonism suggested by animal studies can be translated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Saline + saline | Double saline infusion followed by an ad libitum meal |
| OTHER | Neurotensin + saline | Neurotensin + saline infusion followed by an ad libitum meal |
| OTHER | GLP-1 + saline | GLP-1 + saline infusion followed by an ad libitum meal |
| OTHER | GLP-1 + Neurotensin | GLP-1 + Neurotensin infusion followed by an ad libitum meal |
Timeline
- Start date
- 2019-10-01
- Primary completion
- 2024-06-10
- Completion
- 2024-06-30
- First posted
- 2019-12-04
- Last updated
- 2023-05-17
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04186026. Inclusion in this directory is not an endorsement.